Zobrazeno 1 - 2
of 2
pro vyhledávání: ''
Publikováno v:
CNS & Neurological Disorders - Drug Targets. 15:927-934
Erythropoietin (EPO) has been shown to be a key cytokine in the production of erythrocytes from erythroblasts. Recently, attempts have been made to adopt EPO as a drug target for neuroprotection in selected neurological pathologies. In the current st
Autor:
Yumei Wang, Richard P. E. van Dokkum, Sjoerd W. Landheer, Hendrik Buikema, Robert H. Henning, Peter Vavrinec, Leo E. Deelman
Publikováno v:
Current Vascular Pharmacology, 12(6), 836-844. BENTHAM SCIENCE PUBL LTD
Type 2 diabetes mellitus (T2DM) is associated with risk for chronic kidney disease (CKD), which is associated with a decrease in renal myogenic tone - part of renal autoregulatory mechanisms. Novel class of drugs used for the treatment of T2DM, dipep